| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin II receptor associated protein | 0.890 | 0.115 | 0.19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
apelin | 0.497 | 0.769 | 0.46 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
heart and neural crest derivatives expressed 1 | 0.686 | 0.308 | 0.11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
heart and neural crest derivatives expressed 2 | 0.612 | 0.500 | 0.40 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
translocase of outer mitochondrial membrane 70 | 0.805 | 0.308 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
O-linked N-acetylglucosamine (GlcNAc) transferase | 0.626 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
microtubule associated protein 1 light chain 3 alpha | 0.610 | 0.654 | 2.8E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
steroidogenic acute regulatory protein | 0.513 | 0.808 | 8.8E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glycogen phosphorylase, muscle associated | 0.650 | 0.577 | 2.0E-13 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ribosomal protein S6 kinase B1 | 0.511 | 0.731 | 0.97 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
S100 calcium binding protein A1 | 0.421 | 0.846 | 6.0E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
solute carrier family 8 member A1 | 0.544 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
TIMP metallopeptidase inhibitor 4 | 0.559 | 0.769 | 3.8E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
very low density lipoprotein receptor | 0.558 | 0.692 | 2.0E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
hepcidin antimicrobial peptide | 0.433 | 0.846 | 8.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
poly(ADP-ribose) polymerase 2 | 0.663 | 0.538 | 2.3E-13 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 |